{
    "title": "115_s2514",
    "content": "The Act may be cited as the \"Preserving Access to Cost Effective Drugs Act\" or the \"PACED Act\". Abrogation of sovereign immunity is addressed in the Act. Title 35, United States Code, is amended to address sovereign immunity, stating that a patent owner cannot assert sovereign immunity as a defense in a derivation proceeding, except under certain circumstances. The amendment to Title 35, United States Code, addresses sovereign immunity in patent proceedings, stating that a foreign state patent owner cannot claim immunity in a Patent Trial and Appeal Board proceeding, subject to certain limitations under the 11th amendment. The amendment to Title 35, United States Code, addresses sovereign immunity in patent proceedings, stating that a foreign state patent owner cannot claim immunity in a Patent Trial and Appeal Board proceeding, subject to certain limitations under the 11th amendment. The amendment includes the abrogation of tribal sovereign immunity, defining covered claims related to patent infringement and the Public Health Service Act, and specifying the meaning of \"Indian tribe\" as per the Indian Self-Determination and Education Assistance Act. The Determination and Education Assistance Act addresses sovereign immunity in patent proceedings, prohibiting Indian tribes from asserting sovereign immunity as a defense in court actions. The amendment also defines \"Indian tribe\" and \"foreign state\" in relation to sovereign immunity. The Indian Self-Determination and Education Assistance Act prohibits patent owners, including Indian tribes, from asserting sovereign immunity as a defense in patent proceedings. Foreign states are also subject to this limitation in court actions. The Office or the Patent Trial and Appeal Board will determine if a patent owner is immune from their jurisdiction as if they were a court of the United States, in accordance with chapter 97 of title 28. This subsection applies only to the extent permitted under the 11th amendment to the Constitution of the United States. The term 'Indian tribe' is defined in section 4(e) of the Indian Self-Determination and Education Assistance Act. A patent owner cannot assert sovereign immunity in inter partes review or court review, except for foreign states. The Patent Trial and Appeal Board will determine if a patent owner is immune from its jurisdiction, following the rules of chapter 97 of title 28. This subsection applies within the limits of the 11th amendment to the US Constitution. In section 326, a new subsection (f) on Sovereign Immunity defines 'foreign state' and 'Indian tribe' as per relevant laws. The Indian Self-Determination and Education Assistance Act prohibits patent owners, including Indian tribes, from asserting sovereign immunity in post-grant reviews or court proceedings. The Patent Trial and Appeal Board will determine immunity for foreign states in such reviews. The Patent Trial and Appeal Board will determine if patent owners, including Indian tribes, are immune from its jurisdiction. Amendments to the Tariff Act of 1930 abrogate tribal sovereign immunity in certain cases. The Patent Trial and Appeal Board will decide on the immunity of patent owners, including Indian tribes. Amendments to the Tariff Act of 1930 eliminate tribal sovereign immunity in specific situations. The liability of States, State officials, and Indian tribes for patent infringement is addressed in Section 296."
}